InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Kim Hyung Heon. Officer active across 2 companies, notably NeuroBo Pharmaceuticals, Inc.. Cumulatively, 5 reports have been recorded. Activity tracked since 11 August 2023. The latest transaction was filed on 23 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Kim Hyung Heon is a declarant linked to MetaVia Inc. and NeuroBo Pharmaceuticals, Inc., where he is CEO & President. The record shows 5 filings in total, and across the recent filings available, the date range runs from 2023-08-14 to 2026-01-27, with amounts associated with tax withholding and individual amounts of EUR 37824.72685592949, EUR 6921.181406390824, EUR 3925.592764542709, EUR 0, and EUR 0.